<ѻýҕl>FDA Approves First Drug to Delay Onset of Type 1 Diabetesѻýҕl> Teplizumab will not be subject to a risk evaluation and mitigation strategy program, after all Nov 18, 2022
<ѻýҕl>FDA Panel Endorses Kidney Disease Drug for Serum Phosphorus Controlѻýҕl> Advisors see need for alternatives, citing suboptimal efficacy and tolerance of approved options Nov 17, 2022
<ѻýҕl>After Rejection, Tenapanor for Kidney Disease Faces FDA's Outside Expertsѻýҕl> Drug's effect on serum phosphorus "small and of unclear clinical significance," say FDA reviewers Nov 15, 2022
<ѻýҕl>FDA OKs First Antibody-Drug Conjugate for Platinum-Resistant Ovarian Cancerѻýҕl> Mirvetuximab soravtansine produced responses in almost a third of patients in pivotal trial Nov 15, 2022
<ѻýҕl>Another Adalimumab Biosimilar Seems Set for Interchangeabilityѻýҕl> Trial data pave way for FDA approval Nov 14, 2022
<ѻýҕl>FDA Authorizes IL-1 Drug for Hospitalized COVID Patientsѻýҕl> Anakinra indicated for patients with pneumonia who are at risk of severe respiratory failure Nov 09, 2022
<ѻýҕl>COVID Spread Through Floors, Walls; Infant Pillow Warning; Paul Pelosi Dischargedѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Nov 04, 2022
<ѻýҕl>Pulse Oximeters Need to Work Better for Dark-Skinned Patients, FDA Panel Saysѻýҕl> Warnings to patients and providers, improved accuracy needed, advisors say Nov 02, 2022
<ѻýҕl>The Updated COVID Boosters Could Have Been Betterѻýҕl> From design to implementation, our bivalent shots missed the mark Oct 26, 2022
<ѻýҕl>FDA Broadens Options for Relapsed/Refractory Multiple Myeloma With Teclistamabѻýҕl> Bispecific antibody achieved durable responses in a majority of heavily pretreated patients Oct 25, 2022
<ѻýҕl>Makena Is Just the Latest in Accelerated Approval Mayhemѻýҕl> Congress must take action to reform the process Oct 24, 2022
<ѻýҕl>FDA Approves New CTLA-4 Inhibitor for Cancer Treatmentѻýҕl> Tremelimumab (Imjudo), in combination with durvalumab, lands approval in advanced liver cancer Oct 24, 2022
<ѻýҕl>Thumbs Down for Genetic Test for Opioid Use Disorder, FDA Advisors Sayѻýҕl> False positives, false negatives remain a concern Oct 21, 2022
<ѻýҕl>Revoke Approval of Preterm Birth Drug, FDA Advisors Sayѻýҕl> Makena is ineffective, argued FDA panel Oct 19, 2022
<ѻýҕl>FDA Moves to Pull Controversial Preterm Birth Drug From the Marketѻýҕl> Briefing data show Makena was ineffective in reducing preterm birth, improving neonatal outcomes Oct 14, 2022
<ѻýҕl>Why I Voted 'No' on the New ALS Drugѻýҕl> Here are the shortcomings I saw in the phase II Relyvrio study Oct 13, 2022
<ѻýҕl>FDA Approves At-Home Furosemide for Heart Failureѻýҕl> Strong diuretic to become available outside the hospital setting Oct 10, 2022
<ѻýҕl>FDA OKs Tdap Vaccine for Whooping Cough Protection Before Birthѻýҕl> Boostrix vaccine is to be delivered to the unborn child in the third trimester of pregnancy Oct 07, 2022
<ѻýҕl>The Search Is On for Another Xeno Heart Transplant Recipientѻýҕl> Transplant surgeons discuss testing the concept in more humans Oct 04, 2022
<ѻýҕl>FDA's Power Morcellator Warning Tied to Drop in Distant Leiomyosarcomasѻýҕl> Local and regional illness remained unchanged Oct 04, 2022
<ѻýҕl>Dupilumab Gets First FDA-Approved Indication for Prurigo Nodularisѻýҕl> Significant improvement in itch and nodules at 24 weeks seen in two randomized trials Sep 29, 2022
<ѻýҕl>In Wake of Philips Recall, Patients Still Waiting for Sleep Apnea Devicesѻýҕl> Effects of recall reverberate through sleep medicine community Sep 21, 2022
<ѻýҕl>Gene Therapy for Degenerative Brain Disorder Wins FDA Nodѻýҕl> $3 million price tag for one-time treatment Sep 19, 2022
<ѻýҕl>FDA Finally OKs First Drug for Hepatorenal Syndromeѻýҕl> Pivotal trial data showed terlipressin nearly doubled reversal of the condition Sep 15, 2022
<ѻýҕl>First TYK2 Inhibitor for Psoriasis Wins FDA Approvalѻýҕl> Deucravacitinib significantly outperformed apremilast in two randomized trials Sep 11, 2022
<ѻýҕl>First Approved Treatment for Generalized Pustular Psoriasisѻýҕl> Spesolimab led to complete clearance of pustules within a week in more than half of patients Sep 07, 2022
<ѻýҕl>FDA Data Link Diabetes Drug Class to Gallbladder Diseaseѻýҕl> FAERS analysis turns up dozens of cases of acute cholecystitis tied to GLP-1 receptor agonists Aug 30, 2022
<ѻýҕl>FDA Warns on Potential for Monkeypox Spread via Fecal Transplantѻýҕl> Agency urges additional protections around donor screening Aug 24, 2022
<ѻýҕl>Biden Administration Authorizes Intradermal Use of Monkeypox Vaccineѻýҕl> Move is expected to increase available doses by five-fold Aug 10, 2022
<ѻýҕl>False Claims About COVID Vax Animal Testing Resurfaceѻýҕl> Misinformation promoted by Texas lawmaker in 2021 pops up again on Twitter Aug 09, 2022
<ѻýҕl>I Got Monkeypox Drugs -- Not Everyone Is So Luckyѻýҕl> Increasing access to testing, vaccination, and treatment is critical to slowing the spread Aug 03, 2022
<ѻýҕl>FDA OKs First Interchangeable Ranibizumab Biosimilarѻýҕl> When available, Cimerli qualifies for pharmacy-level substitution for reference drug Aug 03, 2022
<ѻýҕl>Are Skin Lesion Analyzers Ready for Prime Time?ѻýҕl> FDA panel not fully on board to reclassify computer-aided melanoma detection devices Jul 30, 2022
<ѻýҕl>Dear Insurers: It's Time to Cover Weight Loss Drugsѻýҕl> Universal coverage can increase medication access and improve population health Jul 27, 2022
<ѻýҕl>Banned Supplements Still Available to Buy Online After FDA Warningsѻýҕl> FDA should follow up on warning letters, researchers urge Jul 26, 2022
<ѻýҕl>Topical JAK Inhibitor OK'd for Repigmentation of Vitiligoѻýҕl> Significantly more patients achieved 75%, 90% improvement Jul 19, 2022
<ѻýҕl>FDA Getting Tougher on Birth Tissue Companiesѻýҕl> Agency calls out manufacturer on orthopedic indications Jul 06, 2022
<ѻýҕl>FDA Warns of Increased Mortality Risk With Duvelisibѻýҕl> Drug approved for adults with CLL/SLL Jul 01, 2022
<ѻýҕl>FDA Expands Use of Weight-Loss Drug to Adolescentsѻýҕl> Qsymia now approved for teens with obesity, along with diet and exercise Jun 28, 2022
<ѻýҕl>Should Young and Healthy Patients Take Paxlovid?ѻýҕl> The antiviral has not been shown to be valuable in this population Jun 26, 2022